Foslevodopa

Foslevodopa is a medication which acts as a prodrug for levodopa, originally invented in the 1980s but not developed for medical use at that time.^[1] It is approved for use in a subcutaneous infusion as a fixed-dose combination with foscarbidopa for the treatment of Parkinson's disease, under the brand name Vyalev.^[2][3]

Foslevodopa

Identifiers
IUPAC name (2S)-2-Amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic acid
CAS Number	97321-87-4
PubChem CID	127766
DrugBank	DB16683
ChemSpider	113330
UNII	37NQZ0J76I
KEGG	D11839
ChEBI	CHEBI:192509
ChEMBL	ChEMBL4594379
CompTox Dashboard (EPA)	DTXSID70905957
Chemical and physical data
Formula	C9H12NO7P
Molar mass	277.169 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)OP(=O)(O)O
InChI InChI=1S/C9H12NO7P/c10-6(9(12)13)3-5-1-2-8(7(11)4-5)17-18(14,15)16/h1-2,4,6,11H,3,10H2,(H,12,13)(H2,14,15,16)/t6-/m0/s1 Key:YNDMEEULGSTYJT-LURJTMIESA-N